My recent field of interest is cardiotoxicity in cancer patients. I have, in fact, experience in the application of the myocardial deformation parameters (strain, strain rate, and rotation) in those subjects that are potentially affected by a reduction in the heart’s function as a consequence of the cancer treatment.